arrow_back Back to App

Ending legal protection for drug manufacturers in health emergencies

This act removes special legal protection for companies making drugs and medical products used in health emergencies. This means citizens can now seek compensation for harm or injury from these products, which was previously difficult. The act aims to increase accountability and public trust.
Key points
Removes special legal immunity for manufacturers of drugs and medical products during health crises.
Citizens regain the right to seek compensation for harm related to these products.
The act applies to ongoing cases and those initiated after its enactment.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_4388
Sponsor: Rep. Massie, Thomas [R-KY-4]
Process start date: 2025-07-15
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

PREP Repeal Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_4388.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-07-15.

What are the main provisions?

Key points include:

  • Removes special legal immunity for manufacturers of drugs and medical products during health crises.
  • Citizens regain the right to seek compensation for harm related to these products.
  • The act applies to ongoing cases and those initiated after its enactment.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Massie, Thomas [R-KY-4].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Courts and Law